Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
ACER | Acer Therapeutics Inc. | Schelling Chris | President & CEO | Nov 29, 2022 | Buy | $1.22 | 819,672 | 1,000,000 | 2,712,529 | Dec 01, 2022, 04:02 PM | |
ACER | Acer Therapeutics Inc. | ASELAGE STEVE | Director | Nov 29, 2022 | Buy | $1.22 | 409,836 | 500,000 | 483,741 | Dec 01, 2022, 04:01 PM | |
ACER | Acer Therapeutics Inc. | ASELAGE STEVE | Director | Dec 10, 2021 | Buy | $2.04 | 7,984 | 16,287 | 73,905 | Dec 13, 2021, 04:02 PM | |
ACER | Acer Therapeutics Inc. | ASELAGE STEVE | Director | Dec 09, 2021 | Buy | $2.15 | 2,016 | 4,334 | 65,921 | Dec 13, 2021, 04:02 PM | |
ACER | Acer Therapeutics Inc. | ASELAGE STEVE | Director | Jul 24, 2020 | Buy | $3.50 | 45,000 | 157,500 | 63,905 | Jul 28, 2020, 09:02 AM | |
ACER | Acer Therapeutics Inc. | DUNN JOHN MICHAEL | Director | Jul 24, 2020 | Buy | $3.50 | 21,428 | 74,998 | 27,380 | Jul 28, 2020, 09:01 AM | |
ACER | Acer Therapeutics Inc. | Joseph Donald | Chief Legal Officer and Secy | Jul 24, 2020 | Buy | $3.50 | 14,285 | 49,998 | 14,285 | Jul 28, 2020, 09:01 AM | |
ACER | Acer Therapeutics Inc. | Schelling Chris | President & CEO | Jul 24, 2020 | Buy | $3.50 | 142,857 | 500,000 | 1,892,857 | Jul 28, 2020, 09:00 AM | |
ACER | Acer Therapeutics Inc. | Andrews William T. | Chief Medical Officer | Mar 02, 2020 | Option Exercise | $3.28 | 3,142 | 10,306 | 5,858 | Mar 04, 2020, 04:25 PM | |
ACER | Acer Therapeutics Inc. | ASELAGE STEVE | Director | Jul 03, 2019 | Buy | $3.72 | 5,000 | 18,581 | 18,905 | Jul 05, 2019, 04:08 PM | |
ACER | Acer Therapeutics Inc. | Leatt Gary | 10% Owner | Aug 01, 2018 | Buy | $18.00 | 275,000 | 4,950,000 | 1,697,709 | Aug 22, 2018, 04:22 PM | |
ACER | Acer Therapeutics Inc. | Leatt Gary | 10% Owner | Dec 12, 2017 | Buy | $12.00 | 333,333 | 3,999,996 | 1,422,709 | Jan 12, 2018, 02:33 PM | |
ACER | Acer Therapeutics Inc. | ASELAGE STEVE | Director | Dec 14, 2017 | Buy | $12.00 | 2,000 | 24,000 | 13,905 | Dec 18, 2017, 04:01 PM | |
OPXA | Opexa Therapeutics, Inc. | BARABE TIMOTHY C | Director | Nov 18, 2016 | Sale | $0.55 | 14,914 | 8,210 | 20,719 | Nov 22, 2016, 07:31 AM | |
OPXA | Opexa Therapeutics, Inc. | BARABE TIMOTHY C | Director | Sep 17, 2014 | Buy | $1.15 | 10,000 | 11,500 | 16,000 | Sep 18, 2014, 08:00 AM | |
OPXA | Opexa Therapeutics, Inc. | Warma Neil K | President & CEO | Sep 16, 2014 | Buy | $1.11 | 10,000 | 11,100 | 107,634 | Sep 17, 2014, 08:00 AM | |
OPXA | Opexa Therapeutics, Inc. | Seaman Scott B | Director | Dec 18, 2013 | Buy | $1.70 | 30,000 | 51,000 | 40,913 | Dec 18, 2013, 03:58 PM | |
OPXA | Opexa Therapeutics, Inc. | Radhakrishnan Karthik | Chief Financial Officer | Dec 18, 2013 | Buy | $1.70 | 8,000 | 13,600 | 58,000 | Dec 18, 2013, 03:55 PM | |
OPXA | Opexa Therapeutics, Inc. | Warma Neil K | President & CEO | Sep 24, 2013 | Option Exercise | $1.91 | 8,076 | 15,425 | 17,315 | Sep 26, 2013, 09:15 PM | |
OPXA | Opexa Therapeutics, Inc. | JORDEN DAVID EMERSON | Director | Sep 24, 2013 | Option Exercise | $1.91 | 61,912 | 118,252 | 293,456 | Sep 26, 2013, 09:00 PM | |
OPXA | Opexa Therapeutics, Inc. | Seaman Scott B | Director | Sep 24, 2013 | Option Exercise | $1.91 | 269,182 | 514,138 | 518,708 | Sep 26, 2013, 08:57 PM | |
OPXA | Opexa Therapeutics, Inc. | Radhakrishnan Karthik | Chief Financial Officer | Aug 08, 2013 | Buy | $1.50 | 50,000 | 75,000 | 50,000 | Aug 09, 2013, 08:00 AM | |
OPXA | Opexa Therapeutics, Inc. | JORDEN DAVID EMERSON | Director | Jun 30, 2013 | Option Exercise | $1.54 | 4,450 | 6,853 | 231,544 | Jul 02, 2013, 02:57 PM | |
OPXA | Opexa Therapeutics, Inc. | Warma Neil K | President & CEO | Jun 30, 2013 | Option Exercise | $1.54 | 581 | 895 | 9,239 | Jul 02, 2013, 02:49 PM | |
OPXA | Opexa Therapeutics, Inc. | Seaman Scott B | Director | Jun 30, 2013 | Option Exercise | $1.54 | 19,345 | 29,791 | 249,526 | Jul 02, 2013, 02:42 PM | |
OPXA | Opexa Therapeutics, Inc. | Warma Neil K | President & CEO | Dec 31, 2012 | Option Exercise | $1.33 | 600 | 798 | 8,658 | Jan 28, 2013, 05:43 PM | |
OPXA | Opexa Therapeutics, Inc. | Seaman Scott B | Director | Dec 31, 2012 | Option Exercise | $1.33 | 19,978 | 26,571 | 230,181 | Jan 24, 2013, 06:50 PM | |
OPXA | Opexa Therapeutics, Inc. | JORDEN DAVID EMERSON | Acting Chief Financial Officer | Dec 31, 2012 | Option Exercise | $1.33 | 4,595 | 6,111 | 227,094 | Jan 24, 2013, 06:15 PM |